Immunogenicity and safety of a respiratory syncytial virus fusion protein (RSV F) nanoparticle vaccine in older adults

BACKGROUND: A preventative strategy for Respiratory Syncytial Virus (RSV) infection constitutes an under-recognized unmet medical need among older adults. Four formulations of a novel recombinant RSV F nanoparticle vaccine (60 or 90 μg RSV F protein, with or without aluminum phosphate adjuvant) admi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Immun Ageing
Main Authors: Fries, Louis, Shinde, Vivek, Stoddard, Jeffrey J., Thomas, D. Nigel, Kpamegan, Eloi, Lu, Hanxin, Smith, Gale, Hickman, Somia P., Piedra, Pedro, Glenn, Gregory M.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5389002/
https://ncbi.nlm.nih.gov/pubmed/28413427
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12979-017-0090-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados